Pacira BioSciences, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Pacira BioSciences, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2011 to Q4 2023.
  • Pacira BioSciences, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $25.5M, a 11.3% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $25.5M +$2.59M +11.3% Dec 31, 2023 10-K 2024-02-29
Q4 2022 $22.9M +$3.94M +20.7% Dec 31, 2022 10-K 2024-02-29
Q4 2021 $19M +$16.5M +655% Dec 31, 2021 10-K 2023-02-28
Q4 2020 $2.52M -$127M -98.1% Dec 31, 2020 10-K 2022-02-28
Q3 2020 $6.61M +$4.81M +267% Sep 30, 2020 10-Q 2020-10-30
Q4 2019 $129M +$10.4M +8.79% Dec 31, 2019 10-K 2021-03-01
Q3 2019 $1.8M Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $1.8M Jun 30, 2019 10-Q 2019-08-08
Q4 2018 $119M -$1.57M -1.31% Dec 31, 2018 10-K 2020-02-21
Q4 2017 $120M -$28.5M -19.2% Dec 31, 2017 10-K 2019-02-28
Q4 2016 $149M +$16.6M +12.6% Dec 31, 2016 10-K 2018-02-28
Q4 2015 $132M +$775K +0.59% Dec 31, 2015 10-K 2017-03-01
Q4 2014 $131M +$9.86M +8.11% Dec 31, 2014 10-K 2016-02-25
Q4 2013 $121M +$17.5M +16.9% Dec 31, 2013 10-K 2015-02-24
Q4 2012 $104M +$20.7M +24.9% Dec 31, 2012 10-K 2014-02-25
Q4 2011 $83.2M Dec 31, 2011 10-K 2013-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.